# FDA Inspection 1050331 - Takeda Pharamaceutical Company Limited - April 10, 2018

Source: https://www.keypedia.com/records/fda_inspections/takeda-pharamaceutical-company-limited/133a9cc5-8239-42fe-8e7d-c8ff47fdd6ae
Source feed: FDA_Inspections

> FDA Inspection 1050331 for Takeda Pharamaceutical Company Limited on April 10, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050331
- Company Name: Takeda Pharamaceutical Company Limited
- Inspection Date: 2018-04-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1274303 - 2025-06-06](https://www.keypedia.com/records/fda_inspections/takeda-pharamaceutical-company-limited/d7a387ed-5276-41d8-894f-77bea6156cd4)
- [FDA Inspection 1099094 - 2019-07-17](https://www.keypedia.com/records/fda_inspections/takeda-pharamaceutical-company-limited/c2dc0a0b-0042-4b86-831a-04fac0fdf08f)

Company: https://www.keypedia.com/companies/takeda-pharamaceutical-company-limited/dd8ea3d2-c1ad-4e50-aadb-1c84da3652fd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d